title: Gastric bacterial overgrowth accompanies profound acid suppression.
abstract: BACKGROUND
  Suppression of gastric acid may lead to gastric colonization by aerobic and anaerobic bacteria, and consequent clinical manifestations. The risk is likely to be higher with poor environmental hygiene.
  
  
  OBJECTIVE
  To study the effect of short-term acid suppression with omeprazole on gastric bacterial flora.
  
  
  METHODS
  Twenty-five ambulatory patients with acid-peptic diseases underwent clinical assessment and gastric juice collection (for pH and culture) prior to start of therapy with 20 mg omeprazole daily, on days 7 and 14 of therapy, and 7 days after omission of therapy (day 21).
  
  
  RESULTS
  Eighteen patients completed the study. The median gastric pH was 1.8, 7.5, 7.5 and 3.4 on days 0, 7, 14 and 21 respectively. Positive gastric cultures were obtained in 13 of 25, 17 of 21, 18 of 18 and 14 of 18 patients on respective study days, with median colony counts of 1.5 x 10(4), 7.5 x 10(5), 8.7 x 10(7) and 7.3 x 10(4) cfu/mL respectively. Three patients developed self-limiting diarrhea during therapy and two more immediately after discontinuing therapy.
  
  
  CONCLUSIONS
  Gastric colonization is common with short-term profound acid-suppression, and may cause diarrhea. Acid suppressive therapy should be used with caution especially in patients with poor environmental hygiene.
authors.affiliation: Department of Gastroenterology, K E M Hospital, Bombay.
authors.forename: T A
authors.initials: TA
authors.lastname: Patel
authors.forename: P
authors.initials: P
authors.lastname: Abraham
authors.forename: V J
authors.initials: VJ
authors.lastname: Ashar
authors.forename: S J
authors.initials: SJ
authors.lastname: Bhatia
authors.forename: P S
authors.initials: PS
authors.lastname: Anklesaria
mesh_terms: D000328:Adult; D000897:Anti-Ulcer Agents / Q000627:therapeutic use*; D001419:Bacteria / Q000254:growth & development* / Q000302:isolation & purification; D004755:Enterobacteriaceae / Q000254:growth & development; D005260:Female; D005744:Gastric Acid / Q000378:metabolism*; D005753:Gastric Mucosa / Q000187:drug effects / Q000378:metabolism; D006801:Humans; D008297:Male; D008875:Middle Aged; D009853:Omeprazole / Q000627:therapeutic use*; D013210:Staphylococcus / Q000254:growth & development; D013270:Stomach / Q000382:microbiology*
chemical_list: D000897:Anti-Ulcer Agents; D009853:Omeprazole